Mineralocorticoid receptor haplotype, oral contraceptives and emotional information processing

Neuroscience

Volumn 286, Issue , 2015, Pages 412-422

  Hamstra, D A ^a   de Kloet, E R ^c   van Hemert, A M ^b   de Rijk, R H ^d   Van der Does, A J W ^a,b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d DynaCorts Therapeutics   (Netherlands)

Author keywords

Cognition; Emotional information processing; Mineralocorticoid receptor; Oral contraceptives

Indexed keywords

CONTRACEPTIVE AGENT; MINERALOCORTICOID RECEPTOR; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DECISION MAKING; DEPRESSION; DRUG EFFECT; EMOTIONALITY; FACIAL EXPRESSION; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; LUTEAL PHASE; MEASUREMENT ACCURACY; MEMORY ASSESSMENT; MOOD; PREMENOPAUSE; RECOGNITION; WESTERN EUROPEAN; DRUG EFFECTS; EMOTION; GENETICS; PHYSIOLOGY; RECALL; YOUNG ADULT;

ADULT; CONTRACEPTIVES, ORAL, HORMONAL; CROSS-SECTIONAL STUDIES; DECISION MAKING; EMOTIONS; FACIAL EXPRESSION; FEMALE; HAPLOTYPES; HUMANS; MENTAL RECALL; RECEPTORS, MINERALOCORTICOID; RECOGNITION (PSYCHOLOGY); YOUNG ADULT;

EID: 84920109932     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.12.004     Document Type: Article

References (57)

1. Alexander G.M., Sherwin B.B., Bancroft J., Davidson D.W. Testosterone and sexual behavior in oral contraceptive users and nonusers: a prospective study. Horm Behav 1990, 24:388-402.
2. Anderson N. Likableness ratings of 555 personality-trait words. J Pers Soc Psychol 1968, 9:272-279.
3. Bobst C., Sauter C., Foppa A., Lobmaier J. Early testosterone level predicts preference for masculinity in male faces - but not for women taking hormonal contraceptives. Psychoneuroendocrinology 2014, 41:142-150.
4. Boron W, Boulpaep E (2012). Medical physiology. Second Ed., Saunders Ed, Phil, USA.
5. Carey M.P., Deterd C.H., de Koning J., Helmerhorst F., de Kloet E.R. The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. J Endocrinol 1995, 144:311-321.
6. Cobey K.D., Buunk A.P. Conducting high-quality research on the psychological impact of oral contraceptive use. Contraception 2012, 86:330-331.
7. Cobey K.D., Buunk A.P., Roberts S.C., Klipping C., Appels N., Zimmerman Y., et al. Reported jealousy differs as a function of menstrual cycle stage and contraceptive pill use: a within-subjects investigation. Evol Hum Behav 2012, 33:395-401.
8. Cooper S.E., Goings S.P., Kim J.Y., Wood R.I. Testosterone enhances risk tolerance without altering motor impulsivity in male rats. Psychoneuroendocrinology 2014, 40:201-212.
9. Cullberg J. Mood changes and menstrual symptoms with symptoms in women taking oral contraceptives. Br J Psych Scand 1972, 236:1-86.
10. DeBondt T., Jacquemyn Y., Sijbers J., VanHecke W., Sunaert S., Parizel P. Regional gray matter volume differences and sex-hormone correlations as a function of menstrual cycle phase and hormonal contraceptives use. Brain Res 2013, 1530:22-31.
11. De Kloet E.R., Joëls M., Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005, 6:463-476.
12. DeRijk R.H., van Leeuwen N., Klok M.D., Zitman F.G. Corticosteroid receptor-gene variants: modulators of the stress-response and implications for mental health. Eur J Pharmacol 2008, 585:492-501.
13. Derntl B., Kryspin-Exner I., Fernbach E., Moser E., Habel U. Emotion recognition accuracy in healthy young females is associated with cycle phase. Horm Behav 2008, 53:90-95.
14. Deijen D.B., Duyn K., Jansen W., Klitsie J. Use of monophasic, low-dose oral contraceptives in relation to mental functioning. Contraception 1992, 46:539-567.
15. Dreher J.C., Schmidt P.J., Kohn P., Furman D., Rubinow D., Berman K.F. Menstrual cycle phase modulates reward related neural function in women. Proc Natl Acad Sci U S A 2007, 104:2465-2470.
16. Ekman P., Friesen W. Measuring facial movement. Environ Psychol Nonverbal Behav 1976, 1:56-75.
17. Ellis A.J., Wells T.T., Vanderlind W.M., Beevers C.G. The role of controlled attention on recall in major depression. Cogn Emot 2014, 28:520-529. http://dx.doi.org/10.1080/02699931.2013.832153.
18. Fritzsche A., Dahme B., Joormann J., Gotlib I.H., Magnussen H., Watz H., von Leupoldt A. Specificity of cognitive biases in patients with current depression and remitted depression and in patients with asthma. Psychol Med 2009, 40:815-826. 10.1017/S0033291709990948.
19. Gasbarri A., Pompili A., d'Onofrio A., Cifariello A., Tavares M., Tomaz C. Working memory for emotional facial expressions: role of the estrogen in young women. Psychoneuroendocrinology 2008, 33:964-972.
20. Gingnell M., Engman J., Frick A., Moby L., Wikstro J., Fredrikson M., Sundstrom-Poromaa I. Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill. Psychoneuroendocrinology 2012, 2:1. dx.doi.org/10.1016/j.psyneuen.2013.02.014.
21. Guapo V.G., Graeff F.G., Zani A.C.T., Labate C.M., dos Reis R.M., Del-Ben C.M. Effects of sex hormonal levels and phases of the menstrual cycle in the processing of emotional faces. Psychoneuroendocrinology 2009, 34:1087-1094. 10.1016/j.psyneuen.2009.02.007.
22. Hampson E., van Anders S.M., Mullin L.I. A female advantage in the recognition of emotional facial expressions: test of an evolutionary hypothesis. Evol Hum Behav 2006, 27:401-416.
23. Hamstra D.A., De Rover M., De Rijk R.H., Van der Does A.J.W. Oral contraceptives may alter the detection of emotions in facial expressions. Eur Neuropsychopharmacol 2014, 11:1855-1859.
24. Hather R., Trussel J., Cates W., Stewart F., Kowal D. Contraceptive technology 2007, Ardent Media, New York. 19th rev ed.
25. Hoekstra H.A., Ormel J., de Fruyt F. Handleiding NEO persoonlijkheids-vragenlijsten NEO-PI-R en NEO-FFI 1996, Swets Test Services, Lisse.
26. Jarva J., Oinonen K. Do oral contraceptives act as mood stabilizers? Evidence of positive affect stabilization. Arch Womens Ment Health 2007, 10:225-234.
27. Joëls M., Sarabdjitsingh R.A., Karst H. Unraveling the time domains of corticosteroid hormone influences on brain activity: rapid, slow, and chronic modes. Pharmacol Rev 2012, 64:901-938.
28. Joormann J., Gotlib I. Selective attention to emotional faces following recovery from depression. J Abnorm Psychol 2007, 116:80-85. 10.1037/0021-843X.116.1.80.
29. Joormann J., Talbot L., Gotlib I. Biased processing of emotional information in girls at risk for depression. J Abnorm Psychol 2007, 116:135-143. 10.1037/0021-843X.116.1.135.
30. Kirschbaum C., Kudielka B.M., Gaab J., Schommer N.S., Hellhammer D.H. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom Med 1999, 61:154-162.
31. Klok M., Giltay E., van der Does A., Geleijnse J., Antypa N., Penninx B., de Geus E., Willemsen G., Boomsma D., van Leeuwen N., Zitman F., de Kloet R., DeRijk R. A common and functional mineralocorticoid receptor haplotype enhances optimism and protects against depression in females. Translat Psychiatry 2011, 1:1-8.
32. Klok M., Irurzun-Lafitte A., Turner J., Lakke E., Huitinga I., Muller C., Zitman F., de Kloet E., DeRijk R. Decreased expression of mineralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder. J Psychiatr Res 2011, 45:871-878.
33. Women's health 2002, Guilford Press, New York, USA. first ed. S.G. Kornstein, A.H. Clayton (Eds.).
34. Kutner S., Brown W. Types of oral contraceptives, depression, and premenstrual symptoms. J Nerv Ment Dis 1972, 155:153-162.
35. Little A.C., Burriss R.P., Petrie M., Jones B., Roberts C. Oral contraceptive use in women changes preferences for male facial masculinity and is associated with partner facial masculinity. Psychoneuroendocrinology 2013, http://dx.doi.org/10.1016/j.psyneuen.2013.02.014.
36. Milders M., Bell S., Platt J., Serrano R., Runcie O. Stable expression recognition abnormalities in unipolar depression. Psychiatry Res 2010, 179:38-42.
37. Nielsen S.E., Segal S.K., Worden I.V., Yimb I.S., Cahill L. Hormonal contraception use alters stress responses and emotional memory. Biol Psychol 2013, 92:257-266.
38. Oinonen K., Mazmanian D. To what extent do oral contraceptives influence mood and affect?. J Affect Disord 2002, 70:229-240.
39. Ossewaarde L., van Hermans E., Wingen G., Kooijman S., Johansson I., Bäckström T., Fernández G. Neural mechanisms underlying changes in stress-sensitivity across the menstrual cycle. Psychoneuroendocrinology 2010, 35:47-55.
40. Ossewaarde L., van Wingen G.A., Kooijman S.C., Bäckström T., Fernández G., Hermans E.J. Changes in functioning of mesolimbic incentive processing circuits during the premenstrual phase. SCAN 2011, 6:612-620.
41. Otte C., Moritz S., Yassourdis A., Koop M., Madrischewski A., Wiedemann K. Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition. Neuropsychopharmacology 2007, 32:232-238.
42. Pletzer B., Kronbichler M., Aichhorn M., Bergmann J., Ladurner G., Kerschbaum H.H. Menstrual cycle and hormonal contraceptive use modulate human brain structure. Brain Res 2010, 1348:55-62.
43. Pletzer B., Kronbichler M., Nuerk H.C., Kerschbaum H. Hormonal contraceptives masculinize brain activation patterns in the absence of behavioral changes in two numerical tasks. Brain Res 2014, 1543:128-142.
44. Quinkler M., Meyer B., Bumke-Vogt C., Grossmann C., Gruber U., Oelkers W., Diederich S., Bähr V. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor. Eur J Endocrinol 2002, 146:789-799.
45. Rivera R., Yacobson I., Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol 1999, 181:1263-1269.
46. Rogers R.D., Tunbridge E.M., Bhagwagar Z., Drevets W.C., Sahakian B.J., Carter C.S. Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology 2003, 28:153-162.
47. Stanton S.J., Liening S.H., Schultheiss O.C. Testosterone is positively associated with risk taking in the Iowa Gambling Task. Horm Behav 2010, 59:252-256.
48. Svendal G., Berk M., Pasco J.A., Jacka F.N., Lun A., Williams J.A. The use of hormonal contraceptive agents and mood disorders in women. J Affect Disord 2012, 140:92-96.
49. Toffol E., Heikinheimo O., Koponen P., Luoto R., Partonen T. Further evidence for lack of negative associations between hormonal contraception and mental health. Contraception 2012, 86:470-480.
50. Terburg D., Aarts H., van Honk J. Testosterone affects gaze aversion from angry faces outside of conscious awareness. Psycholog Sci 2012, 23:459-463.
51. Van der Does A.J.W. Cognitive reactivity to sad mood: structure and validity of a new measure. Behav Res Ther 2002, 40:105-120.
52. Vessey M.P., McPherson K., Lawless M., Yeates D. Oral contraception and serious psychiatric illness: absence of an association. Br J Psychiatry 1985, 146:45-49.
53. Watson D., Clark L., Tellegen A. Development and validation of brief measures of Positive and Negative Affect: the PANAS scales. J Pers Soc Psychol 1988, 54:1063-1070.
54. Wirth M.M., Schultheiss O.C. Basal testosterone moderates responses to anger faces in humans. Physiol Behav 2007, 90:496-505.
55. Wood R.I., Armstrong A., Fridkin V., Shah V., Najafi A., Jakowec M. Roid rage in rats? Testosterone effects on aggressive testosterone and risk tolerance, motivation, impulsivity and tyrosine hydroxylase. Physiol Behav 2013, 110-111:6-12.
56. Young A.W., Rowland D., Calder A.J., Etcoff N.L. Facial expression megamix: tests of dimensional and category accounts of emotion recognition. Cognition 1997, 3:271-313.
57. Zimmerman Y., Eijkemans M.J.C., Coelingh Bennink H.J.T., Blankenstein M.A., Fauser B.C.J.M. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Hum Reprod Updat 2013, 1-30.